This page contains a list of policy questions that have been formulated by the Health Development Policy Agency together with all the main units that manage the Ministry of Health's priority programs.
Policy questions should be formulated considering strategic health issues, having a broad impact on society, specific and measurable, solution-oriented, and supported by evidence. Health observers can choose the policy questions below as a guide or inspiration for developing policy studies/research and subsequently contributing to improving health policy.
| No. | Suggestion Recommendation The policy that implemented 2025 | Program Unit | Policy Questions |
| 1. | Study of the List of Essential Medical Devices. | Directorate of Production and Distribution of Medical Devices, Directorate General of Pharmaceutical and Medical Devices | What is the method for compiling the List of Essential Medical Devices that can be used as a reference in the procurement, production and distribution of medical devices in Indonesia as mandated in PP 28 of 2024? |
| 2. | Policy for Implementing Investigations into Criminal Cases of Medical Devices by PPNS of the Ministry of Health. | Directorate of Medical Device Supervision, Directorate General of Pharmaceutical and Medical Devices | How prepared are PPNS in the Ministry of Health in conducting criminal case investigations in the field of medical devices? What are the obstacles faced by PPNS in carrying out criminal investigations in criminal case investigations in the field of medical devices? Who are the stakeholders involved in the investigation process in criminal case investigations in the field of medical devices? |
| 3. | Evaluation of Clinical Observation Methods as Evidence-based Methodology for Natural Medicines (OBA) used in Health Services. | Director of Pharmaceutical and Medical Device Resilience, Directorate General of Pharmaceutical and Medical Devices | 1. Are clinical trials using certain methods required as clinical evidence for the use of OBA? 2. What are the opportunities for clinical observation as an evidence-based methodology in the development of phytopharmaceuticals? |
| 4 | Independent strategy for the implementation of Plasma Fractionation in Indonesia. | Directorate of Pharmaceutical Production and Distribution, Directorate General of Pharmaceutical and Health Equipment | What is the strategy to reduce dependence on imported PODP? What is the strategy to build a plasma fractionation facility within 2-3 years? What is the strategy to utilize plasma that is not used in health services so that it can be used as raw material for PODP production? What is the strategy to improve the quality and supply of plasma for fractionation? What is the strategy to distribute plasma effectively and efficiently in a country with geographical conditions like Indonesia? |
| 5 | Integrated and Sustainable Healthy Area Vulnerability Assessment | Directorate of Environmental Health, Directorate General of P2 | What are the behaviors in society that can increase the risk of climate-sensitive diseases (dengue) and what environmental risk factors influence it? |
| 6 | Study to realize Integrated and Sustainable Healthy Areas. | Directorate of Non-Communicable Diseases, Directorate General of P2, Directorate of Environmental Health, Directorate General of P2, Directorate of Health Promotion and Group Health, Directorate General of Kesprimkom | How to develop integrated and sustainable healthy area policies? |
| 7. | Study of the Concept of Safety Supervision of Ready-to-Eat Food in Indonesia. | Directorate of Environmental Health, Directorate General of P2 | How does the Indonesian government have guidelines for implementing the safety of ready-to-eat processed food that are in accordance with health standards and are implementable in the community? |
| 8. | Evaluation of the Implementation of Risk Based Assessment (RBA) in the Discovery of Disease Cases and/or Health Risk Factors with the Potential to Cause Extraordinary Events (KLB)/Outbreaks at the Tanjung Priok BBKK and Banten Class 1 BKK | Directorate of Health Surveillance and Quarantine, Directorate General of P2 | How is RBA implemented in the discovery of disease cases and/or health risk factors on ships at BBKK Tanjung Priok and BKK Class 1 Banten? |
| 9. | Strategy to Improve the Accuracy of National Immunization Program Targets Through Target Data Harmonization | Directorate of Immunization, Directorate General of P2 | 1. How can the verification and validation mechanisms for immunization target data be strengthened at the central and regional levels? 2. How big is the impact of different estimation methods on planning and achieving immunization coverage? 3. Has the digital-based immunization recording system been adopted evenly, and how effective is it in improving data accuracy? 4. Tolerance limits / correction figures for immunization program achievements? |
| 10. | Recommendations for poisoning management policies (natural and non-natural) in health facilities in Indonesia and socialization of poisoning guidelines. | Center for Health Resilience Systems, BKPK | What is the strategy to improve good governance in the context of handling poisoning at the primary or referral level, and will it have a positive impact on patient safety and increase the preparedness of health workers in dealing with various cases of natural and non-natural poisoning that occur in the community with the existence of this natural and non-natural poisoning guidebook? |
| 11. | Policy recommendations for initiating the establishment of a Poison Center in Indonesia with a virtual Poison Center system as its basis. | Center for Health Resilience Systems, BKPK | What is the best way to establish a comprehensive, integrated, and easily accessible poison control center using modern systems such as a Virtual Poison Center that provides quick access to first aid information, provides educational materials on poisoning prevention and treatment, and uses AI technology? |
| 12. | Policy recommendations for the development of new antivenoms and their production in Indonesia. | Center for Health Resilience Systems, BKPK | How to use new strategies in the study of new antivenom research needs and their production according to the type of species and venom effects of snakes, venomous animals, poisonous plants and fungi as well as research and antidotes for medicinal materials, pesticides, heavy metals, food and drinks, microplastics and household chemicals that cause poisoning in Indonesia? |
